{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:42:02Z","timestamp":1794282122222,"version":"4.9.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100013061","name":"Jilin Provincial Scientific and Technological Development Program","doi-asserted-by":"publisher","award":["YDZJ202201ZYTS110"],"award-info":[{"award-number":["YDZJ202201ZYTS110"]}],"id":[{"id":"10.13039\/501100013061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02593-z","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T14:33:30Z","timestamp":1737729210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["Correlation between atherogenic index of plasma and cardiovascular disease risk across Cardiovascular\u2013kidney\u2013metabolic syndrome stages 0\u20133: a nationwide prospective cohort study"],"prefix":"10.1186","volume":"24","author":[{"given":"Yaohua","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenpeng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"issue":"10440","key":"2593_CR1","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"AJ Ferrari","year":"2024","unstructured":"Ferrari AJ, Santomauro DF, Aali A, Abate YH, Abbafati C, Abbastabar H, Abd ElHafeez S, Abdelmasseh M, Abd-Elsalam S, Abdollahi A, et al. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of Disease Study 2021. Lancet. 2024;403(10440):2133\u201361.","journal-title":"Lancet"},{"issue":"3","key":"2593_CR2","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1213\/ANE.0000000000006975","volume":"139","author":"S Roth","year":"2024","unstructured":"Roth S, M\u2019Pembele R, Matute P, Kotfis K, Larmann J, Lurati Buse G. Cardiovascular\u2013kidney\u2013metabolic syndrome: Association with adverse events after major noncardiac surgery. Anesth Analgesia. 2024;139(3):679\u201381.","journal-title":"Anesth Analgesia"},{"key":"2593_CR3","first-page":"5","volume":"21","author":"SLM Suh","year":"2014","unstructured":"Suh SLM. Metabolic syndrome and cardiovascular diseases in Korea. J Atheroscler Thromb. 2014;21:5.","journal-title":"J Atheroscler Thromb"},{"key":"2593_CR4","doi-asserted-by":"crossref","unstructured":"Marassi M, Fadini GP. The cardio-renal-metabolic connection: a review of the evidence. Cardiovasc Diabetol 2023;22(1).","DOI":"10.1186\/s12933-023-01937-x"},{"issue":"12","key":"2593_CR5","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1111\/dom.14829","volume":"24","author":"T Kadowaki","year":"2022","unstructured":"Kadowaki T, Maegawa H, Watada H, Yabe D, Node K, Murohara T, Wada J. Interconnection between cardiovascular, renal and metabolic disorders: a narrative review with a focus on Japan. Diabetes Obes Metabolism. 2022;24(12):2283\u201396.","journal-title":"Diabetes Obes Metabolism"},{"issue":"20","key":"2593_CR6","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, Coresh J, Mathew RO, Baker-Smith CM, Carnethon MR, et al. Cardiovascular\u2013kidney\u2013metabolic health: a Presidential Advisory from the American Heart Association. Circulation. 2023;148(20):1606\u201335.","journal-title":"Circulation"},{"key":"2593_CR7","doi-asserted-by":"crossref","unstructured":"Ostrominski JW, Arnold SV, Butler J, Fonarow GC, Hirsch JS, Palli SR, Donato BMK, Parrinello CM, O\u2019Connell T, Collins EB et al. Prevalence and overlap of Cardiac, Renal, and metabolic conditions in US adults, 1999\u20132020. JAMA Cardiol 2023;8(11).","DOI":"10.1001\/jamacardio.2023.3241"},{"issue":"11","key":"2593_CR8","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1007\/s00125-018-4700-5","volume":"61","author":"A Rosengren","year":"2018","unstructured":"Rosengren A, Edqvist J, Rawshani A, Sattar N, Franz\u00e9n S, Adiels M, Svensson A-M, Lind M, Gudbj\u00f6rnsdottir S. Excess risk of hospitalisation for heart failure among people with type 2 diabetes. Diabetologia. 2018;61(11):2300\u20139.","journal-title":"Diabetologia"},{"issue":"1","key":"2593_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2215\/CJN.03610414","volume":"10","author":"Y-C Tsai","year":"2015","unstructured":"Tsai Y-C, Chiu Y-W, Tsai J-C, Kuo H-T, Hung C-C, Hwang S-J, Chen T-H, Kuo M-C, Chen H-C. Association of fluid overload with cardiovascular morbidity and all-cause mortality in stages 4 and 5 CKD. Clin J Am Soc Nephrol. 2015;10(1):39\u201346.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"2593_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2174\/1573403X12666160606120254","volume":"12","author":"MC Thomas","year":"2016","unstructured":"Thomas MC. Type 2 diabetes and heart failure: challenges and solutions. Curr Cardiol Rev. 2016;12(3):249\u201355.","journal-title":"Curr Cardiol Rev"},{"issue":"5","key":"2593_CR11","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/ejhf.1170","volume":"20","author":"PM Seferovi\u0107","year":"2018","unstructured":"Seferovi\u0107 PM, Petrie MC, Filippatos GS, Anker SD, Rosano G, Bauersachs J, Paulus WJ, Komajda M, Cosentino F, de Boer RA, et al. Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018;20(5):853\u201372.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"2593_CR12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jash.2007.01.010","volume":"1","author":"P Yerram","year":"2007","unstructured":"Yerram P, Karuparthi PR, Hesemann L, Horst J, Whaley-Connell A. Chronic kidney disease and cardiovascular risk. J Am Soc Hypertens. 2007;1(3):178\u201384.","journal-title":"J Am Soc Hypertens"},{"key":"2593_CR13","doi-asserted-by":"crossref","unstructured":"Tain Y-L, Hsu C-N. Melatonin use during pregnancy and lactation complicated by oxidative stress: focus on offspring\u2019s Cardiovascular\u2013Kidney\u2013Metabolic health in animal models. Antioxid (Basel) 2024;13(2).","DOI":"10.3390\/antiox13020226"},{"issue":"6","key":"2593_CR14","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s11255-013-0407-1","volume":"45","author":"S Olechnowicz-Tietz","year":"2013","unstructured":"Olechnowicz-Tietz S, Gluba A, Paradowska A, Banach M, Rysz J. The risk of atherosclerosis in patients with chronic kidney disease. Int Urol Nephrol. 2013;45(6):1605\u201312.","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"2593_CR15","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/jdi.13985","volume":"14","author":"MK Khanal","year":"2023","unstructured":"Khanal MK, Bhandari P, Dhungana RR, Gurung Y, Rawal LB, Pandey G, Bhandari M, Bhuiyan R, Devkota S, de Courten M, et al. Electrocardiogram abnormalities and renal impairment in patients with type 2 diabetes mellitus: a healthcare facilities-based cross-sectional study in Dang district of Nepal. J Diabetes Investig. 2023;14(4):602\u201313.","journal-title":"J Diabetes Investig"},{"key":"2593_CR16","doi-asserted-by":"publisher","first-page":"1412857","DOI":"10.3389\/fcvm.2024.1412857","volume":"11","author":"JWM Fowler","year":"2024","unstructured":"Fowler JWM, Song L, Tam K, Roth Flach RJ. Targeting lymphatic function in Cardiovascular\u2013kidney\u2013metabolic syndrome: preclinical methods to analyze lymphatic function and therapeutic opportunities. Front Cardiovasc Med. 2024;11:1412857.","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"2593_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.arcmed.2019.08.009","volume":"50","author":"JC Fern\u00e1ndez-Mac\u00edas","year":"2019","unstructured":"Fern\u00e1ndez-Mac\u00edas JC, Ochoa-Mart\u00ednez AC, Varela-Silva JA, P\u00e9rez-Maldonado IN. Atherogenic index of plasma: novel predictive biomarker for cardiovascular illnesses. Arch Med Res. 2019;50(5):285\u201394.","journal-title":"Arch Med Res"},{"key":"2593_CR18","doi-asserted-by":"crossref","unstructured":"Nam JS, Kim MK, Nam JY, Park K, Kang S, Ahn CW, Park JS. Association between atherogenic index of plasma and coronary artery calcification progression in Korean adults. Lipids Health Dis 2020;19(1).","DOI":"10.1186\/s12944-020-01317-4"},{"key":"2593_CR19","doi-asserted-by":"crossref","unstructured":"You F-F, Gao J, Gao Y-N, Li Z-H, Shen D, Zhong W-F, Yang J, Wang X-M, Song W-Q, Yan H et al. Association between atherogenic index of plasma and all-cause mortality and specific-mortality: a nationwide population\u2013based cohort study. Cardiovasc Diabetol 2024;23(1).","DOI":"10.1186\/s12933-024-02370-4"},{"key":"2593_CR20","doi-asserted-by":"crossref","unstructured":"Min Q, Wu Z, Yao J, Wang S, Duan L, Liu S, Zhang M, Luo Y, Ye D, Huang Y et al. Association between atherogenic index of plasma control level and incident cardiovascular disease in middle-aged and elderly Chinese individuals with abnormal glucose metabolism. Cardiovasc Diabetol 2024;23(1).","DOI":"10.1186\/s12933-024-02144-y"},{"issue":"2","key":"2593_CR21","first-page":"50","volume":"18","author":"SA Althwab","year":"2024","unstructured":"Althwab SA, Abdulmonem WA, Allemailem KS, Alarifi SA, Hamad EM. Prediction of cardiovascular risk factors and metabolic syndrome in adults from Saudi Arabia using the logarithm of triglyceride\/HDL-cholesterol ratio. Int J Health Sci (Qassim). 2024;18(2):50\u20135.","journal-title":"Int J Health Sci (Qassim)"},{"issue":"1","key":"2593_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43(1):61\u20138.","journal-title":"Int J Epidemiol"},{"key":"2593_CR23","doi-asserted-by":"crossref","unstructured":"Li W, Shen C, Kong W, Zhou X, Fan H, Zhang Y, Liu Z, Zheng L. Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with Cardiovascular\u2013kidney\u2013metabolic syndrome stage 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol 2024;23(1).","DOI":"10.1186\/s12933-024-02352-6"},{"issue":"12","key":"2593_CR24","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1093\/eurheartj\/ehad885","volume":"45","author":"D He","year":"2024","unstructured":"He D, Wang Z, Li J, Yu K, He Y, He X, Liu Y, Li Y, Fu R, Zhou D, et al. Changes in frailty and incident cardiovascular disease in three prospective cohorts. Eur Heart J. 2024;45(12):1058\u201368.","journal-title":"Eur Heart J"},{"key":"2593_CR25","doi-asserted-by":"publisher","first-page":"101264","DOI":"10.1016\/j.eclinm.2021.101264","volume":"44","author":"K Gao","year":"2022","unstructured":"Gao K, Cao L-F, Ma W-Z, Gao Y-J, Luo M-S, Zhu J, Li T, Zhou D. Association between Sarcopenia and cardiovascular disease among middle-aged and older adults: findings from the China health and retirement longitudinal study. EClinicalMedicine. 2022;44:101264.","journal-title":"EClinicalMedicine"},{"issue":"6","key":"2593_CR26","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RB D\u2019Agostino","year":"2008","unstructured":"D\u2019Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care. Circulation. 2008;117(6):743\u201353.","journal-title":"Circulation"},{"key":"2593_CR27","doi-asserted-by":"publisher","first-page":"g14","DOI":"10.1136\/bmj.g14","volume":"348","author":"VWV Jaddoe","year":"2014","unstructured":"Jaddoe VWV, de Jonge LL, Hofman A, Franco OH, Steegers EAP, Gaillard R. First trimester fetal growth restriction and cardiovascular risk factors in school age children: population based cohort study. BMJ. 2014;348:g14.","journal-title":"BMJ"},{"issue":"4","key":"2593_CR28","doi-asserted-by":"publisher","first-page":"e12869","DOI":"10.1111\/mcn.12869","volume":"15","author":"LG Bjerregaard","year":"2019","unstructured":"Bjerregaard LG, Pedersen DC, Mortensen EL, S\u00f8rensen TIA, Baker JL. Breastfeeding duration in infancy and adult risks of type 2 diabetes in a high-income country. Matern Child Nutr. 2019;15(4):e12869.","journal-title":"Matern Child Nutr"},{"key":"2593_CR29","doi-asserted-by":"crossref","unstructured":"duiyimuhan G, Maimaiti N. The association between atherogenic index of plasma and all-cause mortality and cardiovascular disease-specific mortality in hypertension patients: a retrospective cohort study of NHANES. BMC Cardiovasc Disord 2023;23(1).","DOI":"10.1186\/s12872-023-03451-0"},{"key":"2593_CR30","doi-asserted-by":"crossref","unstructured":"Zhang Y, Chen S, Tian X, Wang P, Xu Q, Xia X, Zhang X, Li J, Liu F, Wu S et al. Association between cumulative atherogenic index of plasma exposure and risk of myocardial infarction in the general population. Cardiovasc Diabetol 2023;22(1).","DOI":"10.1186\/s12933-023-01936-y"},{"key":"2593_CR31","doi-asserted-by":"crossref","unstructured":"Alifu J, Xiang L, Zhang W, Qi P, Chen H, Liu L, Yin G, Mohammed A-Q, Lv X, Shi T et al. Association between the atherogenic index of plasma and adverse long-term prognosis in patients diagnosed with chronic coronary syndrome. Cardiovasc Diabetol 2023;22(1).","DOI":"10.1186\/s12933-023-01989-z"},{"key":"2593_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejim.2024.03.024","volume":"125","author":"FA Abdu","year":"2024","unstructured":"Abdu FA, Alifu J, Mohammed A-Q, Liu L, Zhang W, Yin G, Lv X, Mohammed AA, Mareai RM, Xu Y, et al. The correlation of atherogenic index of plasma with non-obstructive CAD and unfavorable prognosis among patients diagnosed with MINOCA. Eur J Intern Med. 2024;125:111\u20139.","journal-title":"Eur J Intern Med"},{"key":"2593_CR33","doi-asserted-by":"crossref","unstructured":"Yin B, Wu Z, Xia Y, Xiao S, Chen L, Li Y. Non-linear association of atherogenic index of plasma with insulin resistance and type 2 diabetes: a cross-sectional study. Cardiovasc Diabetol 2023;22(1).","DOI":"10.1186\/s12933-023-01886-5"},{"key":"2593_CR34","doi-asserted-by":"crossref","unstructured":"Qin M, Chen B. Association of atherogenic index of plasma with cardiovascular disease mortality and all-cause mortality in the general US adult population: results from NHANES 2005\u20132018. Cardiovasc Diabetol 2024;23(1).","DOI":"10.1186\/s12933-024-02359-z"},{"key":"2593_CR35","doi-asserted-by":"crossref","unstructured":"Cai G, Liu W, Lv S, Wang X, Guo Y, Yan Z, Du Y, Zhou Y. Gender-specific associations between atherogenic index of plasma and the presence and severity of acute coronary syndrome in very young adults: a hospital-based observational study. Lipids Health Dis 2019;18(1).","DOI":"10.1186\/s12944-019-1043-2"},{"key":"2593_CR36","doi-asserted-by":"publisher","first-page":"117389","DOI":"10.1016\/j.atherosclerosis.2023.117389","volume":"387","author":"J Deng","year":"2023","unstructured":"Deng J, Tang X, Tang R, Chen J, Guo H, Zhou Q, Zhan X, Long H, Peng F, Wang X, et al. Atherogenic index predicts all-cause and cardiovascular mortality in incident peritoneal dialysis patients. Atherosclerosis. 2023;387:117389.","journal-title":"Atherosclerosis"},{"key":"2593_CR37","doi-asserted-by":"crossref","unstructured":"Zheng X, Zhang X, Han Y, Hu H, Cao C. Nonlinear relationship between atherogenic index of plasma and the risk of prediabetes: a retrospective study based on Chinese adults. Cardiovasc Diabetol 2023;22(1).","DOI":"10.1186\/s12933-023-01934-0"},{"issue":"1","key":"2593_CR38","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12933-024-02198-y","volume":"23","author":"M Rabiee Rad","year":"2024","unstructured":"Rabiee Rad M, Ghasempour Dabaghi G, Darouei B, Amani-Beni R. The association of atherogenic index of plasma with cardiovascular outcomes in patients with coronary artery disease: a systematic review and meta-analysis. Cardiovasc Diabetol. 2024;23(1):119.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"2593_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/08037051.2019.1583060","volume":"28","author":"MK Choudhary","year":"2019","unstructured":"Choudhary MK, Er\u00e4ranta A, Koskela J, Tikkakoski AJ, Nevalainen PI, K\u00e4h\u00f6nen M, Mustonen J, P\u00f6rsti I. Atherogenic index of plasma is related to arterial stiffness but not to blood pressure in normotensive and never-treated hypertensive subjects. Blood Press. 2019;28(3):157\u201367.","journal-title":"Blood Press"},{"issue":"3","key":"2593_CR40","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1756-185X.2011.01595.x","volume":"14","author":"M Karimi","year":"2011","unstructured":"Karimi M, Mazloomzadeh S, Kafan S, Amirmoghadami H. The frequency of metabolic syndrome in women with rheumatoid arthritis and in controls. Int J Rheum Dis. 2011;14(3):248\u201354.","journal-title":"Int J Rheum Dis"},{"issue":"18","key":"2593_CR41","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1177\/1535370220940992","volume":"245","author":"EA Tagoe","year":"2020","unstructured":"Tagoe EA, Dwamena-Akoto E, Nsaful J, Aikins AR, Clegg-Lamptey J-N, Quaye O. High atherogenic index of plasma and cardiovascular risk factors among Ghanaian breast cancer patients. Exp Biol Med (Maywood). 2020;245(18):1648\u201355.","journal-title":"Exp Biol Med (Maywood)"},{"key":"2593_CR42","doi-asserted-by":"crossref","unstructured":"Yen C-H, Chang P-S, Chiu C-J, Huang Y-Y, Lin P-T. \u03b2-Carotene status is Associated with inflammation and two components of metabolic syndrome in patients with and without Osteoarthritis. Nutrients 2021;13(7).","DOI":"10.3390\/nu13072280"},{"key":"2593_CR43","doi-asserted-by":"crossref","unstructured":"Rajkumari R, Abhijeet J, Gujaram M, Dhone PG, Neeta R. Association of serum high-sensitivity creactive protein level with metabolic syndrome. Int J Health Sci (Qassim) 2022:10162\u20138.","DOI":"10.53730\/ijhs.v6nS1.7223"},{"key":"2593_CR44","doi-asserted-by":"crossref","unstructured":"Kir S, Ekiz K, Alacam H, Turkel R, Koroglu E, Altintop BL, The association between pro and anti-inflammatory markers with the components of metabolic syndrome. Acta Endocrinol (Buchar). 2019;15(4):430\u20135.","DOI":"10.4183\/aeb.2019.430"},{"issue":"8","key":"2593_CR45","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/dmrr.1144","volume":"26","author":"J Tournoy","year":"2010","unstructured":"Tournoy J, Lee DM, Pendleton N, O\u2019Neill TW, O\u2019Connor DB, Bartfai G, Casanueva FF, Finn JD, Forti G, Giwercman A, et al. Association of cognitive performance with the metabolic syndrome and with glycaemia in middle-aged and older European men: the European Male Ageing Study. Diabetes Metab Res Rev. 2010;26(8):668\u201376.","journal-title":"Diabetes Metab Res Rev"},{"key":"2593_CR46","doi-asserted-by":"crossref","unstructured":"Syauqy A, Hsu C-Y, Rau H-H, Kurniawan AL, Chao JCJ. Association of Sleep Duration and Insomnia Symptoms with components of metabolic syndrome and inflammation in Middle-aged and older adults with metabolic syndrome in Taiwan. Nutrients 2019;11(8).","DOI":"10.3390\/nu11081848"},{"issue":"14","key":"2593_CR47","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","volume":"385","author":"W Zhang","year":"2021","unstructured":"Zhang W, Zhang S, Deng Y, Wu S, Ren J, Sun G, Yang J, Jiang Y, Xu X, Wang T-D, et al. Trial of intensive blood-pressure control in older patients with hypertension. N Engl J Med. 2021;385(14):1268\u201379.","journal-title":"N Engl J Med"},{"key":"2593_CR48","doi-asserted-by":"crossref","unstructured":"Xie W, Zheng F, Yan L, Zhong B. Cognitive decline before and after incident coronary events. J Am Coll Cardiol. 2019;73(24):3041\u201350.","DOI":"10.1016\/j.jacc.2019.04.019"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02593-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02593-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02593-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T14:33:46Z","timestamp":1737729226000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02593-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2593"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02593-z","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"assertion":[{"value":"23 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was approved by the Peking University Institutional Review Board and carried out in compliance with the ethical standards outlined in the Declaration of Helsinki. Field personnel performed standardized, verified interviews in compliance with the Declaration of Helsinki\u2019s ethical norms and with approval from the Peking University Institutional Review Board, and all participants gave their informed permission.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}